Condition
Macular Hole Surgery
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07318961Not ApplicableRecruitingPrimary
Autologous Tenon's Capsule Graft for Refractory Macular Holes
NCT06908824Not ApplicableRecruiting
No Endotamponade for Macular Hole Repair: the NEMAR Study
NCT06685328Not ApplicableEnrolling By Invitation
Minimal Vitrectomy and ILM Flap with Sodium Hyaluronate Gel for MH
NCT02894424CompletedPrimary
Effect of the Membrane Blue Dual® Dye on the Retinal Sensitivity in Macular Hole Surgery
NCT02650739CompletedPrimary
Optical Coherence Tomography-based Positioning for Macular Hole Surgery
Showing all 5 trials